Page last updated: 2024-10-16

aminolevulinic acid and Xeroderma Pigmentosum

aminolevulinic acid has been researched along with Xeroderma Pigmentosum in 4 studies

Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.

Xeroderma Pigmentosum: A rare, pigmentary, and atrophic autosomal recessive disease. It is manifested as an extreme photosensitivity to ULTRAVIOLET RAYS as the result of a deficiency in the enzyme that permits excisional repair of ultraviolet-damaged DNA.

Research Excerpts

ExcerptRelevanceReference
" Currently, aminolevulinic acid-mediated dPDT has been approved to treat actinic keratosis patients in Europe."5.05Daylight Photodynamic Therapy: An Update. ( Chen, H; Hsu, R; Lee, CN; Wong, TW, 2020)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Fernández-Guarino, M1
Mavura, D1
Fernández-González, P1
Chapa, P1
Ravazzano, C1
Jaén, L1
Rios, L1
Jaén, P1
Grossman, H1
Lee, CN1
Hsu, R1
Chen, H1
Wong, TW1
Wolf, P1
Kerl, H1
el-Sharabasy, MM1
Hegazy, AA1
el-Soubky, MS1
el-Maksoud, MA1

Reviews

1 review available for aminolevulinic acid and Xeroderma Pigmentosum

ArticleYear
Daylight Photodynamic Therapy: An Update.
    Molecules (Basel, Switzerland), 2020, Nov-08, Volume: 25, Issue:21

    Topics: Aminolevulinic Acid; Animals; Antineoplastic Agents; Bowen's Disease; Carcinoma, Basal Cell; Cheilit

2020

Other Studies

3 other studies available for aminolevulinic acid and Xeroderma Pigmentosum

ArticleYear
Daylight photodynamic therapy is an option for the treatment of actinic keratosis in patients with xeroderma pigmentosum in Africa.
    Photodiagnosis and photodynamic therapy, 2020, Volume: 29

    Topics: Adolescent; Adult; Africa; Aminolevulinic Acid; Child; Child, Preschool; Female; Humans; Infant; Ker

2020
Photodynamic therapy in patient with xeroderma pigmentosum.
    Lancet (London, England), 1991, Jun-29, Volume: 337, Issue:8757

    Topics: Administration, Topical; Aminolevulinic Acid; Carcinoma, Squamous Cell; Female; Humans; Middle Aged;

1991
Porphyrins and nucleic acid in some photosensitive skin diseases.
    Acta medica Hungarica, 1990, Volume: 47, Issue:1-2

    Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; DNA; Hemoglobins; Humans; Porphyrins; Protoporphyrins; R

1990